Sun, Feb 1, 2015, 8:12 PM EST - U.S. Markets closed

Recent

% | $
Quotes you view appear here for quick access.

HALLMARK VENTURE GRP Message Board

  • jameskrakom jameskrakom Mar 15, 2011 11:04 AM Flag

    Clutching at straws

    Some desperate straw-clutching going on here:


    "Management is pleased to report that preliminary results of a Pharmacokinetic study conducted in dogs (beagle) by an independent Contract Research Organization, following strictly regulated protocols, using coded products with Ibuprofen formulation according to Spencer Pharmaceutical Inc. patented formulations, showed the rapid release of the active ingredient."

    Woopy doo.


    Ironically all this PR does is emphasise just how far away Spencer's controlled release products are from being launched in any market, if ever. Animal testing of this sort is a sine qua non for any drug candidate and needs to be followed by years of human studies costing many millions of dollars.

    No respectable Pharma company would PR such an inconsequential piece of "news".

    A thoroughly disreputable one like Spencer Pharma would though, presumably to distract attention from the fact that the (entirely fictional) buy-out of SPPH by Al-Dora/Al-Dorra/Al Durrah/Hail First Pharma (none of which exist outside of SPPH's fraudulent PRs) is at least 30 days behind schedule:

    "Management of Spencer is keeping Al-Dorra and its subsidiary Hail First Pharma updated on these exciting new developments as they are diligently working on the buyout transactions and continuing updates are scheduled to be released to shareholders."

    Yeah, right. Liars.


    http://ih.advfn.com/p.php?pid=nmona&article=46881354&symbol=SPPH

    SortNewest  |  Oldest  |  Most Replied Expand all replies
 
HLLK
0.00010.0000(0.00%)Oct 10 10:29 AMEDT

Trending Tickers

i
Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.